tirzepatide is it glp 1 Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of | Cardiovascular Diabetology Troubling Findings in Study of

Patients with CS show phenotypical characteristics including moon face, facial plethora, striae rubrae, supraclavicular and dorsal fat pads (86) and several comorbidities including DM, visceral obesity dyslipidaemia, cardiovascular disease, osteoporosis and vertebral fractures, infections and neuropsychiatric disorders, which can sometimes persist even after the disease is cured and contribute to increased mortality, compared to the general population (87, 88)

They can assess whether the fatigue is related to the medication, your diabetes management, or other health factors, and provide appropriate guidance tailored to your individual circumstances

PlexusDx recommends coordinating with your primary care physician or endocrinologist to adjust thyroid medication doses as your weight stabilizes

TABLE 1 Carnitine transporters involved in cancer